Beatriz Paoli Thompson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beatriz Paoli Thompson has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- José Geraldo Mill
Universidade Federal do Espirito Santo, Brazil
4 shared publications - Bárbara Sthefany de Paula Lacerda
Hospital Universitário Cassiano Antonio Moraes, Universidade Federal do Espírito Santo (HU-CAM-UFES)
3 shared publications - Isac Ribeiro Moulaz
Centro de Ciências da Saúde, Medicina, Universidade Federal do Espírito Santo, Vitória 29047-105, Brazil
3 shared publications - Karen Evelin Monlevade Lança
Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
3 shared publications - Thayná Martins Gouveia
Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
3 shared publications - Valéria Valim
Hospital Universitário Cassiano Antônio Moraes (HUCAM), Universidade Federal do Espírito Santo (UFES), Vitória 29041-295, ES, Brazil
3 shared publications
Latest Publications
- Open Access
- 10 July 2023
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 27 (4) , 102789
Pulmonary function and exercise capacity six months after hospital discharge of patients with severe COVID-19
- 10 July 2023
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 27 (4) , 102789
Open AccessPulmonary function and exercise capacity six months after hospital discharge of patients with severe COVID-19
- Open Access
- 10 February 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 101713
REATIVIDADE VACINAL E DURAÇÃO DE RESPOSTA IMUNE DA CORONAVAC E ASTRAZENECA EM UMA COORTE DE TRABALHADORES
- 10 February 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 101713
Open AccessREATIVIDADE VACINAL E DURAÇÃO DE RESPOSTA IMUNE DA CORONAVAC E ASTRAZENECA EM UMA COORTE DE TRABALHADORES
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 55, e01062022
Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence
This study aimed to evaluate IgG and IgM levels in COVID-19 recurrence. The serum antibody levels and clinical data from 73 healthcare workers with SARS-CoV-2 divided into seroconverted (n=51) and non-seroconverted (n=22) groups were assessed. The presence of specific anti-nucleocapsid (anti-N) IgM and IgG for SARS-CoV-2 was evaluated. IgG antibodies to the SARS-CoV-2 spike receptor-binding domain were used to confirm non-seroconversion in all negative anti-N. Four recurrent cases displayed mild symptoms and were non-seroconverted until the recurrence of symptoms. Undetectable anti-nucleocapsid IgM and IgG levels may be correlated with symptomatic COVID-19 recurrence.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 55, e01062022
Open AccessAnti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence
This study aimed to evaluate IgG and IgM levels in COVID-19 recurrence. The serum antibody levels and clinical data from 73 healthcare workers with SARS-CoV-2 divided into seroconverted (n=51) and non-seroconverted (n=22) groups were assessed. The presence of specific anti-nucleocapsid (anti-N) IgM and IgG for SARS-CoV-2 was evaluated. IgG antibodies to the SARS-CoV-2 spike receptor-binding domain were used to confirm non-seroconversion in all negative anti-N. Four recurrent cases displayed mild symptoms and were non-seroconverted until the recurrence of symptoms. Undetectable anti-nucleocapsid IgM and IgG levels may be correlated with symptomatic COVID-19 recurrence.